发明名称 |
6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES |
摘要 |
The present invention provides novel compounds of formula (I) wherein R is selected from the group consisting of R2, R2NH-, or H2N-R3- wherein R2 is selected from the group consisting of C1-C8 alkyl and formula (II), wherein Z is selected from the group consisting of phenyl, heterocycle and cycloalkyl, each R4 is independently hydrogen or C1-C4 alkyl, and n is an integer 1-8; wherein each C1-C8 alkyl and Z is optionally substituted with 1 to 3 substituents, which may be the same or different, selected from the group consisting of Hal, OH, and C1-C4 alkyl; R3 is C1-C8 alkylene; and R1 is selected from the group consisting of cyclopentyl and isopropyl, and the pharmaceutically acceptable salts, optical isomers, and hydrates thereof. In addition, the present invention provides a method of inhibiting cell cycle progression. More specifically, the present invention provides a method of inhibiting cyclin dependent kinases, particularly cdk-2. The present invention also provides a method of preventing apoptosis in neuronal cells and a method of inhibiting the development of neoplasms. In addition, the present invention provides a composition comprising an assayable amount of a compound of formula (I) in admixture or otherwise in association with an inert carrier. The present invention also provides a pharmaceutical composition comprising an effective inhibitory amount of a compound of formula (I) in admixture or otherwise in association with one or more pharmaceutically acceptable carriers or excipients. |
申请公布号 |
WO9943676(A3) |
申请公布日期 |
1999.10.21 |
申请号 |
WO1999US03451 |
申请日期 |
1999.02.18 |
申请人 |
HOECHST MARION ROUSSEL, INC. |
发明人 |
DUMONT, JENNIFER, A.;BITONTI, ALAN, J.;BORCHERDING, DAVID, R.;PEET, NORTON, P.;MUNSON, H., RANDALL;SHUM, PATRICK, W., K. |
分类号 |
A61K31/52;A61P25/00;A61P35/00;A61P35/02;C07D473/16 |
主分类号 |
A61K31/52 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|